 |
Dépôt minimal $50 Promotion exclusive |
Notre score |
Commission 0% |
Are you looking to buy Biogen stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:BIIB! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Biogen stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin’s lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer’s disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson’s disease and movement disorders; BIIB111 and BIIB112 to treat ophthalmology related diseases; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and TMS-007 to treat acute neurology; BIIB074 and BIIB095 for neuropathic pain; and SB11 and SB15 biosimilars, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; and Ionis Pharmaceuticals, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Volume moyen
1,45 million de shs
CAP DE MARCHÉ
$40.87 billion
Bourse
NASDAQ
Achetez cette action !
|
NOM
|
TICKER
|
INDUSTRIE
|
SECTEUR
|
VOLUME
|
ACHETEZ CETTE ACTION MAINTENANT
|
|---|---|---|---|---|---|
|
NASDAQ:BIIB
|
Produits biologiques, sauf diagnostic
|
Médical
|
15,937 shs
|
Below is a quick guide on how to buy NASDAQ:BIIB stocks safe, fast and around the world in less than five minutes.
Étape 1 : Ouvrir un compte chez eToro – eToro is the best broker to buy Biogen shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Étape 2 : Téléchargez votre ID - Conformément à la réglementation KYC, eToro vous demandera de télécharger une copie de votre passeport ou de votre permis de conduire.
Étape 3 : Dépôt des fonds - Déposez de l'argent sur votre compte eToro nouvellement créé. Vous pouvez choisir entre un virement bancaire, un portefeuille électronique, une carte de débit/crédit ou Paypal.
Étape 4 : Buy Biogen – Search for “”NASDAQ:BIIB”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Biogen stocks with 0% commission!.
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
32 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Biogen in the last twelve months. There are currently 5 sell ratings, 15 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” Biogen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BIIB, but not buy additional shares or sell existing shares.
Wall Street analysts have given Biogen a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Biogen wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
2 |  | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
3 |  | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:BIIB stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Biogen stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Biogen stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Comme eToro est une plateforme réglementée, vous devrez remplir le processus KYC, c'est une pratique standard et cela ne prend que quelques minutes. Vous devrez fournir une pièce d'identité avec photo (passeport, permis de conduire) et un justificatif de domicile (facture d'électricité, relevé bancaire).
Une fois que vous vous êtes inscrit et que vous avez vérifié votre compte, vous devrez déposer des fonds. eToro accepte les cartes de crédit/débit, les virements bancaires et également les portefeuilles électroniques. Donc, quelle que soit votre préférence, il y aura quelque chose pour vous.
Now that you’ve funded your eToro account, just type “NASDAQ:BIIB stocks" dans la barre de recherche en haut de l'écran et appuyez sur "commerce".
All that’s left is to buy some NASDAQ:BIIB stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:BIIB is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Biogen stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Biogen is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for Biogen.
Biogen Inc. (NASDAQ:BIIB) released its quarterly earnings data on Tuesday, February, 2nd. The biotechnology company reported $4.58 EPS for the quarter, missing the consensus estimate of $4.87 by $0.29. The biotechnology company had revenue of $2.85 billion for the quarter, compared to analyst estimates of $2.80 billion. Biogen had a trailing twelve-month return on equity of 51.00% and a net margin of 35.63%. The business’s revenue was down 22.3% on a year-over-year basis. During the same quarter last year, the company earned $8.34 earnings per share.
View Biogen’s earnings history.
Biogen’s stock was trading at $294.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BIIB shares have decreased by 9.3% and is now trading at $267.00.
Biogen declared that its board has approved a stock buyback plan on Monday, December 23rd 2019, which allows the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:BIIB stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Plus de 95% des fonds des clients sont conservés hors ligne, en chambre froide, ce qui est crucial pour tout courtier qui gère vos actifs. Quel que soit le degré de sécurité d'une plateforme, nous vous recommandons d'utiliser le 2FA pour ajouter une couche supplémentaire de sécurité à votre compte.
eToro offre aux utilisateurs une série de fonctionnalités pour commencer à investir le plus rapidement possible. Ils ont une fonction relativement unique appelée copy trading, qui vous permet de gagner un revenu passif en reproduisant des traders expérimentés, cela vous permet de commencer à gagner du profit rapidement, et vous donne une meilleure compréhension des stratégies utilisées par les professionnels. De plus, eToro permet aux utilisateurs d'investir dans des portefeuilles gérés, un portefeuille géré étant une variété d'actifs similaires regroupés, vous permettant de diversifier votre compte, réduisant ainsi tout risque potentiel. Pour ceux qui ont déjà une expérience du trading, vous pouvez investir dans des marchés autres que les actions, car eToro permet aux utilisateurs de négocier des ETF, des matières premières, des crypto et des indices. Si vous investissez déjà en dehors de l'espace boursier, cela peut être très utile, car cela vous permet de gérer tous vos investissements en un seul endroit.
Biogen issued an update on its FY 2021 Pre-Market earnings guidance on Wednesday, February, 3rd. The company provided earnings per share (EPS) guidance of 17.00-18.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $24.67. The company issued revenue guidance of $10.45-10.75 billion, compared to the consensus revenue estimate of $11.22 billion.
32 brokerages have issued 1-year price objectives for Biogen’s shares. Their forecasts range from $175.00 to $450.00. On average, they anticipate Biogen’s share price to reach $304.80 in the next twelve months. This suggests a possible upside of 14.2% from the stock’s current price.
View analysts’ price targets for Biogen or view top-rated stocks among Wall Street analysts.
Les CFD sont des instruments complexes et comportent un risque élevé de perdre rapidement de l'argent en raison de l'effet de levier. 68% des comptes d'investisseurs particuliers perdent de l'argent lorsqu'ils négocient des CFD avec ce fournisseur. Vous devez vous demander si vous comprenez le fonctionnement des CFD et si vous pouvez vous permettre de prendre le risque élevé de perdre votre argent.
Biogen’s management team includes the following people:
Mr. Michel Vounatsos, CEO & Director (Age 59, Pay $5.72M)
Ms. Susan H. Alexander, Exec. VP, Chief Legal Officer & Sec. (Age 64, Pay $1.99M)
Dr. Alfred W. Sandrock Jr., Exec. VP of R&D (Age 63, Pay $1.87M)
Mr. Chirfi Guindo, Exec. VP of Global Product Strategy & Commercialization (Age 55, Pay $1.32M)
Mr. Michael R. McDonnell, Exec. VP & CFO (Age 57)
Ms. Robin C. Kramer, VP & Chief Accounting Officer (Age 55)
Mr. Mark J. Hernon, Sr. VP & Chief Information Officer (Age 57)
Ms. Natacha Gassenbach, Chief Communication Officer & Head of Corp. Affairs
Dr. Ginger Gregory, Exec. VP & Chief HR Officer (Age 53)
Dr. Alphonse Galdes, Exec. VP of Pharmaceutical Operations & Technology (Age 68)
186 employees have rated Biogen CEO Michel Vounatsos on Glassdoor.com. Michel Vounatsos has an approval rating of 86% among Biogen’s employees.
Some companies that are related to Biogen include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR).
View all of BIIB’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Biogen investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), Tesla (TSLA), Alibaba Group (BABA), Amgen (AMGN), The Walt Disney (DIS), Intel (INTC), Micron Technology (MU) and The Boeing (BA).
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
Biogen trades on the NASDAQ under the ticker symbol “BIIB.”
Biogen’s stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.72%), Sumitomo Mitsui Trust Holdings Inc. (0.39%), Swiss National Bank (0.39%), First Trust Advisors LP (0.27%), Candriam Luxembourg S.C.A. (0.25%) and California Public Employees Retirement System (0.25%). Company insiders that own Biogen stock include Alexander J Denner, Alfred Sandrock, Brian S Posner, Michel Vounatsos, Robert W Pangia and Stephen A Sherwin.
View institutional ownership trends for Biogen.
BIIB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Robeco Institutional Asset Management B.V., Los Angeles Capital Management LLC, PGGM Investments, Sumitomo Mitsui Trust Holdings Inc., DNB Asset Management AS, Aperio Group LLC, and Swiss National Bank. Company insiders that have sold Biogen company stock in the last year include Alfred Sandrock, and Stephen A Sherwin.
View insider buying and selling activity for Biogen or view top insider-selling stocks.
BIIB stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., FIL Ltd, State of Wisconsin Investment Board, Cambiar Investors LLC, SG Americas Securities LLC, Candriam Luxembourg S.C.A., AMF Pensionsforsakring AB, and Segantii Capital Management Ltd. Company insiders that have bought Biogen stock in the last two years include Alexander J Denner, and Michel Vounatsos.
View insider buying and selling activity for Biogen or or view top insider-buying stocks.
Shares of BIIB can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revue de Interactive Brokers, Revue d'eToro, Revue DEGiro, Revue d'AvaTrade, Examen d'IG Markets, Revue des marchés IC, Revue de CMC Markets, Revue Admiral Markets et bien d'autres encore. Lisez l'une des critiques pour tout savoir sur le courtier et commencez à acheter des actions dès maintenant.
One share of BIIB stock can currently be purchased for approximately $267.00.
A Reportlab.org, nous voulons nous assurer que vous disposez de toutes les informations les plus pertinentes sur acheter des actions. Nous vous apportons les meilleurs guides sur le marché boursier avec des critiques personnelles, des informations de fond, des critiques de plateformes, des modes d'emploi et plus encore. Vous voulez obtenir d'autres informations ? Alors consultez le Actions OTC, Actions du NASDAQ, Actions du NYSE, Actions LON, Stocks FRA, Stocks ETR, Stocks EPA, Actions de la TSX ou Actions Amex. Vous cherchez des informations plus détaillées comme Stocks de 5g, actions de biotechnologie, stocks d'or et d'autres informations de notre reportlab.
How can you buy Biogen stock on the internet?
You can easily buy Biogen stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Une autre option consiste à utiliser un courtier réglementé comme Marchés IC ou Courtiers interactifs. You can an account with these brokers and start buying or trading NASDAQ:BIIB stocks in a safe and complete environment to trade in.
Where to buy Biogen stock?
You will first want to find a licensed broker that supports NASDAQ:BIIB stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:BIIB stocks in a safe and complete environment.
Is NASDAQ:BIIB stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:BIIB stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Biogen stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:BIIB is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Biogen stock.
How do you trade Biogen stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Biogen stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:BIIB stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Biogen stock?
To sell your NASDAQ:BIIB stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Biogen stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:BIIB stock.
Stephen connaît bien les produits financiers et a notamment une grande passion pour les marchés boursiers et leurs participants. Nous espérons que les informations fournies vous aideront. Quelque chose n'est pas tout à fait clair ? Veuillez laisser vos questions ou commentaires au bas de la page.
| Notre score ★★★★★ | |
| Notre score ★★★★★ | |
| Notre score ★★★★★ |
Bulletin d'information
Nouvelles récentes
| |
Notre score |
Commission 0% |
Données en temps réel sur les actions et les crypto-monnaies
Notifications, conseils et actualités
Guides des meilleures actions et crypto
Critiques sur les courtiers et les bourses en ligne
Reportlab Finance est un site purement informatif et n'implique en aucun cas des conseils en matière d'investissement. Tous les investissements comportent des risques et vous pouvez perdre tous vos investissements. N'investissez pas l'argent que vous ne pouvez pas vous permettre de perdre.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Royaume-Uni
Copyright © 2022 Reportlab.Finance | Tous droits réservés.
